Last July, the agency placed a hold on the trial due to a chromatographic signal detected in a human ADME study of the therapy.

The convergence of AI and drug delivery is opening new frontiers in precision medicine. AI-powered predictive modeling is ...

Insulet Corporation (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its revolutionary Omnipod 5 Automated Insulin ...

Medically reviewed by Isabel Casimiro, MD, PhD A hormonal imbalance occurs when the body has too much or too little of a ...

The future of medicine is being shaped by a confluence of factors at play. If there are worries galore around drug resistant ...

Objectives This study was conducted to determine the predictors of sexual dysfunction and quality of life (QOL) in patients with type 2 diabetes (T2D). Sexual dysfunction is a long-term consequence of ...

Bon Secours St. Francis Health System Ob/Gyn Stephanie Dach is is on a mission to help women navigate perimenopause and ...

Insulet shows bullish trends with strong growth, favorable Wall Street ratings, and a 3.2:1 reward-risk ratio. Read more on ...

Tv Therapeutics' Phase 3 trial for cadisegliatin in type 1 diabetes resumes after FDA lifts hold, with a revised six-month ...

Unmind today announced being named to Fast Company's prestigious list of Most Innovative Companies of 2025 in the Workplace category. The No. 9 ranking globally recognized Unmind's tremendous growth ...

Shardul Nautiyal, Mumbai Tuesday, March 18, 2025, 08:00 Hrs [IST] ...